- Disease: Post-COVID-19
- Study type: Observational Cohort Study
- Study type descriptors: Prospective, Multicentre
- Study aim: To characterise long-term COVID-19 sequelae in populations globally and compare the prevalence of reported symptoms in high-income countries and low-income and middle-income countries
- Number of participants enrolled: 35637
- Study enrolling from to
- Study includes follow-up for 12 months
Study Data
- Adults
- General population
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Blood sample
- Stool sample
External Links
Other information
Funders:
- UK Foreign
- Commonwealth and Development Office and Wellcome
- Bill & Melinda Gates Foundation
- Universityof Oxford’s COVID-19 Research Response Fund
- National Institute for Health Research
- Medical Research Council
- n Emergingand Zoonotic Infections at University of Liverpool in partnership with Public HealthEngland
- Liverpool Experimental Cancer MedicineCentre
- Comprehensive Local Research Networks
- Research Council of Norway
- Vivaldi Invest
- South Eastern Norway Health Authority and the Research Council of Norway
- Innovative Medicines InitiativeJoint Undertaking
- COMBACTE
- Instituto de Salud Carlos III
- INSERM
- Brazil National Councilfor Scientific and Technological Development Scholarship
- Institute for Clinical Research Malaysia
- Universidad de La Sabana
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to